Effect of NPC-15199 on Ca2+ levels in renal tubular cells.
Chung-Ren Jan, Bang-Ping Jiann, Hong-Tai Chang, Cha-Chen Yu, Yih-Chau Lu, Jeng-Hsien Yeh, Wei-Chun Chen, Yee-Ping Law, Jong-Khing Huang
Index: Chin. J. Physiol. 45(3) , 117-22, (2002)
Full Text: HTML
Abstract
In Madin-Darby canine kidney (MDCK) cells, effect of NPC-15199 on intracellular Ca2+ concentration ([Ca2+]i) was investigated by using fura-2. NPC-15199 (100-1000 microM) caused a rapid and sustained increase of [Ca2+]i in a concentration-dependent manner (EC50=500 microM). NPC-15199-induced [Ca2+]i rise was prevented by 70% by removal of extracellular Ca2+, but was not changed by dihydropyridines, verapamil and diltiazem. In Ca2+-free medium, carbonylcyanide m-chlorophenylhydrazone (CCCP; 2 microM), a mitochondrial uncoupler, and thapsigargin (1 microM), an inhibitor of the endoplasmic reticulum (ER) Ca2(+)-ATPase, caused a monophasic [Ca2+]i rise, respectively, after which the increasing effect of NPC-15199 (1 mM) on [Ca2+]i was substantially attenuated; also, pretreatment with NPC-15199 abolished CCCP- and thapsigargin-induced [Ca2+]i rises. U73122, an inhibitor of phospholipase C, [corrected] abolished 10 microM ATP (but not 1 mM NPC-15199)-induced [Ca2+]i rise. These results suggest that NPC-15199 rapidly increases [Ca2+]i by stimulating both extracellular Ca2+ influx and intracellular Ca2+ release via as yet unidentified mechanism(s).
Related Compounds
Related Articles:
2015-06-01
[Cancer Sci. 106 , 747-56, (2015)]
Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
2015-01-01
[PLoS ONE 10 , e0126910, (2015)]
Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model.
2014-01-01
[Sci. Rep. 4 , 6777, (2014)]
2005-09-21
[Chem. Commun. (Camb.) (35) , 4414-6, (2005)]
2010-04-06
[Langmuir 26(7) , 4990-8, (2010)]